S. Lora, R. Jiménez-Galán, E. Prado-Mel, MD Vega-Coca, MA Pérez-Moreno, L. Abdel-Kader Martín
{"title":"5PSQ-037 外周血生物标志物动态预测非鳞状转移性非小细胞肺癌患者对 pembrolizumab 加化疗的临床反应","authors":"S. Lora, R. Jiménez-Galán, E. Prado-Mel, MD Vega-Coca, MA Pérez-Moreno, L. Abdel-Kader Martín","doi":"10.1136/ejhpharm-2024-eahp.371","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"70 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"5PSQ-037 Peripheral blood biomarkers dynamics predict clinical response to pembrolizumab plus chemotherapy in patients with non-squamous metastatic non-small-cell lung cancer\",\"authors\":\"S. Lora, R. Jiménez-Galán, E. Prado-Mel, MD Vega-Coca, MA Pérez-Moreno, L. Abdel-Kader Martín\",\"doi\":\"10.1136/ejhpharm-2024-eahp.371\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":107680,\"journal\":{\"name\":\"Section 5: Patient safety and quality assurance\",\"volume\":\"70 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Section 5: Patient safety and quality assurance\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ejhpharm-2024-eahp.371\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section 5: Patient safety and quality assurance","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2024-eahp.371","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
5PSQ-037 Peripheral blood biomarkers dynamics predict clinical response to pembrolizumab plus chemotherapy in patients with non-squamous metastatic non-small-cell lung cancer